Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platformsÂ
MENLO PARK, Calif. and STAMFORD, Conn., Aug. 7, 2023 /PRNewswire/ PacBio , a leading.
Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms MENLO PARK, Calif. and STAMFORD, Conn., Aug. 7, 2023 /PRNewswire/ PacBio (NASDAQ:PACB), a leading developer of
/PRNewswire/ GeneDx, LLC, a leader in genomic analysis, today announced new research in collaboration with the University of Washington, Seattle Children s.